Central hypothyroidism and cardiovascular disease: a Spanish cohort observational study

Fernando Guerrero-Pérez1,2, Pedro Iglesias3,4, Miguel Paja Fano5,6

  • 1Department of Endocrinology and Nutrition, Hospital Universitari de Bellvitge, Barcelona, Spain. ferguepe@hotmail.com.

Hormones (Athens, Greece)
|August 18, 2025
PubMed

Insights

Central hypothyroidism presents a high prevalence of cardiovascular risk factors. The incidence of these factors, cardiovascular diseases, and mortality were similar in both isolated and combined forms of the condition.

Area of Science:

  • Endocrinology
  • Cardiology
  • Public Health

Background:

  • Central hypothyroidism is a rare endocrine disorder with limited data on associated cardiovascular risks.
  • Understanding cardiovascular risk factors (CVRFs) and diseases (CVDs) is crucial for managing patients with central hypothyroidism.

Purpose of the Study:

  • To investigate the prevalence and incidence of CVRFs, CVDs, and mortality in adults with central hypothyroidism.
  • To compare cardiovascular outcomes between patients with isolated and combined central hypothyroidism.

Main Methods:

  • A multicenter, retrospective, observational study involving 637 patients with central hypothyroidism from 14 Spanish tertiary hospitals.
  • Data collected included baseline demographics, CVRFs, CVDs, and outcomes during a median follow-up of 7.0 years.

Main Results:

  • At baseline, high prevalence of dyslipidemia (34.2%), hypertension (31.4%), and diabetes (13.2%) was observed.
  • Incident CVRFs and CVDs were common during follow-up, with similar rates between isolated and combined central hypothyroidism.
  • Mortality occurred in 7.2% of patients, with infections and CVDs as leading causes.

Conclusions:

  • Central hypothyroidism is associated with a significant burden of cardiovascular risk factors.
  • Cardiovascular disease incidence and mortality do not significantly differ between isolated and combined central hypothyroidism.
  • Further research is needed to elucidate specific management strategies for cardiovascular health in this population.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
32
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
57
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
334
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
78
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
34